[Hormone-dependency of human breast cancer in in vitro clonogenic assay]
- PMID: 3560449
[Hormone-dependency of human breast cancer in in vitro clonogenic assay]
Abstract
The in vitro clonogenic assay has been used to assess the biological effects of estradiol-17 beta (E 2) and an antiestrogen, tamoxifen (TAM) on human breast cancer, and the results were compared with the estrogen receptor status (ER). The sera used were treated with dextran-coated charcoal to avoid the modification effects of the endogenous hormones. There was a significant difference between ER (+) and ER (-) breast cancers in the incidence of cases in which the plating efficiency of cancers increased more than 50% over those of untreated control by adding 10(-8) M of E 2 (40.2% vs. 21.3%). TAM, 10(-6) M revealed a less than 50% colony formation of the control in 30.5% of ER (+) cancers, whereas only 13.0% of ER (-) cancers showed a response to TAM.
Similar articles
-
A possible direct action of a gonadotropin-releasing hormone agonist, goserelin, on the clonogenic growth of human breast cancer.Anticancer Res. 1993 Sep-Oct;13(5A):1443-5. Anticancer Res. 1993. PMID: 8239517
-
Hormone receptors and Japanese breast cancer.Acta Pathol Jpn. 1982;32 Suppl 1:145-54. Acta Pathol Jpn. 1982. PMID: 6764994 Review.
-
Drug and hormone sensitivity of estrogen receptor-positive and -negative human breast cancer cells in vitro.Cancer Res. 1982 Dec;42(12):5147-51. Cancer Res. 1982. PMID: 7139616
-
Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay.Breast Cancer Res Treat. 1985;6(3):229-35. doi: 10.1007/BF01806773. Breast Cancer Res Treat. 1985. PMID: 2936413
-
[Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].Bull Cancer. 1996 Oct;83(10):808-15. Bull Cancer. 1996. PMID: 8952630 Review. French.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical